Highlights: Avecho and Sandoz sign an exclusive ten-year development and license agreement ("Agreement") for Avecho's pharmaceutical cannabidiol capsule for insomnia in AustraliaAvecho to receive ...

CoreWeave, the AI Hyperscalertm, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to a proposed initial ...

This summer is likely to be an emotional time for many in Ulverston.

An Australian biotech minnow wants to become the first company globally to register an over-the-counter cannabidiol product ...

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Our significant investment in research and development underpins our commitment to ...